文献速递外周动脉疾病

血管外科学会间歇性跛行适当使用标准的验证研究

Validation of the Society for Vascular Surgery Appropriate Use Criteria for management of intermittent claudication.
PubMed 文献 · J Vasc Surg · 2026-02-03

本研究为多中心回顾性验证,评估血管外科学会(SVS)间歇性跛行(IC)适当使用标准(AUC)的适用性。共纳入372例患者,按AUC分为适当/不确定(B>R/IND)组和不适当(R>B)组。结果显示R>B组患者2年内免于血运重建率和免于再干预率显著更低,且截肢事件仅发生于R>B组中轻度/中度生活方式受限者。

要点

  • SVS AUC可识别间歇性跛行治疗不适当的患者,其预后显著更差。
  • 不适当治疗组2年免于血运重建率仅19%,适当/不确定组为57%。
  • 截肢事件仅见于不适当治疗且轻度/中度生活方式受限的患者。

核心结论

  • 按SVS AUC评定为不适当(R>B)的间歇性跛行患者,其预后显著差于适当/不确定(B>R/IND)治疗者。

研究设计与样本

  • 多中心回顾性队列研究,纳入2005至2024年七家机构因间歇性跛行治疗的患者372例,按AUC由两名作者评定为B>R、IND或R>B,以患者为单位分析。

主要发现

  • R>B组中Black患者占12.7% vs B>R/IND组6.7%,Hispanic患者占19.8% vs 9.2%(P = .006)。
  • R>B组评估时接受最佳药物治疗者占58.3% vs 75.9%(P < .01)。
  • R>B组轻度或中度生活方式受限者占93.7% vs 68.6%(P < .01),血运重建前接受运动治疗者占22% vs 54%(P < .01)。
  • 从初次血管外科会诊起2年内,R>B组免于血运重建率为19%,B>R/IND组为57%(P < .01)。
  • 血运重建后2年内,R>B组免于再干预率为64%,B>R/IND组为84%(P = .01)。

关键数值与推荐

  • AUC将治疗评定为适当(B>R)、不确定(IND)或不适当(R>B),分析时将B>R与IND合并为B>R/IND组。
  • R>B组2年免于症状复发率为48.9%,B>R/IND组为60%(P = .07)。
  • 研究期间17例患者(4.6%)共发生10例大截肢和11例小截肢。
  • 轻度/中度生活方式受限且评为R>B的患者中,15例(11.8%)接受了9例小截肢和10例大截肢;同等限制但评为B>R/IND者无截肢。

临床怎么用

  • 临床可依据SVS AUC对间歇性跛行患者进行血运重建决策评估,识别不适当治疗的高风险人群。
  • 对轻度/中度生活方式受限患者,应优先优化药物治疗和运动治疗,避免不适当的血运重建。

局限性

  • 本研究为回顾性设计,可能存在选择偏倚和信息偏倚。
  • AUC评定由两名作者完成,虽经讨论解决分歧,但主观性仍可能存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to perform a multi-institutional retrospective validation of the Society for Vascular Surgery Appropriate Use Criteria (AUC) for management of intermittent claudication (IC). METHODS: A retrospective review of patients treated for IC from 2005 to 2024 was performed across seven institutions. Inclusion criteria followed AUC assumptions. All treated limbs were rated as appropriate (benefit outweighs risk [B>R]), indeterminate (IND) or inappropriate (R>B) per the original AUC by two authors, who resolved discrepancies through discussion. Analysis was performed on the patient level. If one limb was rated as R>B, the patient was rated as R>B. For the purposes of comparison, B>R and IND were grouped together (B>R/IND). RESULTS: A total of 372 patients were included. The median follow-up was 1190 days (interquartile range, 433-2115 days). Treatment was classified as B>R/IND in 245 patients (66%) and R>B in 127 (34%). More patients in the R>B group identified as Black (12.7% vs 6.7%) and Hispanic (19.8% vs 9.2%) (P = .006). Fewer patients in the R>B group were on optimal medical therapy at the time of evaluation (58.3% vs 75.9%; P < .01). More patients in R>B had mild or moderate lifestyle limitations (93.7% vs 68.6%; P < .01) and fewer patients in R>B had exercise therapy prior to revascularization (22% vs 54%; P < .01). The most affected segments were aortoiliac (30.9%) and femoropopliteal (49.7%). Revascularization was performed in 231 patients (104 B>R/IND and 127 R>B). Of the patients who underwent revascularization, 149 underwent unilateral revascularization, and 82 underwent bilateral revascularization. Interventions were most often performed in the femoropopliteal (48.1%) and aortoiliac (35.1%) segments. At 2 years from initial consultation with the vascular surgeon, 19% in the R>B group were free from revascularization compared with 57% in the B>R/IND group (P < .01). Freedom from symptom recurrence at 2 years was lower in the R>B group but did not reach statistical significance (48.9% vs 60%; P = .07). Freedom from reintervention at 2 years following revascularization was significantly lower in the R>B group (64% vs 84%; P = .01). A total of 10 major amputations and 11 minor amputations occurred in 17 patients (4.6%) over the study period. Among patients who had mild/moderate lifestyle limitations and were classified as R>B, 15 (11.8%) underwent nine minor amputations and 10 major amputations. Among patients who had mild or moderate lifestyle limitations and were classified as B>R/IND, no patients underwent any type of amputation. CONCLUSIONS: In this retrospective multi-institutional cohort, patients with IC who were treated inappropriately (R>B) per the Society for Vascular Surgery AUC experienced significantly worse outcomes compared with those who received appropriate/indeterminate (B>R/IND) treatment.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Vega AA, Mavilian C, Alabi O, et al. Validation of the Society for Vascular Surgery Appropriate Use Criteria for management of intermittent claudication. J Vasc Surg. 2026. PMID: 41644017. doi:10.1016/j.jvs.2026.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。